Cargando…

Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19

BACKGROUND: Gut microbiota alterations have been reported in hospitalized COVID-19 patients, with reduced alpha diversity and altered microbiota composition related to respiratory failure. However, data regarding gut microbiota and mortality are scarce. METHODS: Rectal swabs for gut microbiota analy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trøseid, Marius, Holter, Jan Cato, Holm, Kristian, Vestad, Beate, Sazonova, Taisiia, Granerud, Beathe K., Dyrhol-Riise, Anne Ma, Holten, Aleksander R., Tonby, Kristian, Kildal, Anders Benjamin, Heggelund, Lars, Tveita, Anders, Bøe, Simen, Müller, Karl Erik, Jenum, Synne, Hov, Johannes R., Ueland, Thor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946863/ https://www.ncbi.nlm.nih.gov/pubmed/36814280 http://dx.doi.org/10.1186/s13054-023-04356-2

Ejemplares similares

High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19
por: Tveita, Anders, et al.
Publicado: (2022)

Persistent T‐cell exhaustion in relation to prolonged pulmonary pathology and death after severe COVID‐19: Results from two Norwegian cohort studies
por: Trøseid, Marius, et al.
Publicado: (2022)

Elevated Levels of Anti-Inflammatory Eicosanoids and Monocyte Heterogeneity in Mycobacterium tuberculosis Infection and Disease
por: Nore, Kristin Grotle, et al.
Publicado: (2020)

CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19
por: Gregersen, Ida, et al.
Publicado: (2022)

Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2020)

Monocytic myeloid‐derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase‐2 inhibitors
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2020)

A Plasma 5-Marker Host Biosignature Identifies Tuberculosis in High and Low Endemic Countries
por: Chendi, Bih H., et al.
Publicado: (2021)

SARS-CoV-2 in the Air Surrounding Patients during Nebulizer Therapy
por: Gohli, Jostein, et al.
Publicado: (2022)

Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure
por: Ueland, T, et al.
Publicado: (2020)

Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial
por: Prebensen, Christian, et al.
Publicado: (2017)

Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice
por: Mortensen, Rasmus, et al.
Publicado: (2019)

Increased inflammatory markers reflecting fibrogenesis are independently associated with cardiac involvement in hospitalized COVID-19 patients
por: Ueland, T, et al.
Publicado: (2021)

DIAGNOSTIC ACCURACY AND ADDED VALUE OF INFECTION BIOMARKERS IN PATIENTS WITH POSSIBLE SEPSIS IN THE EMERGENCY DEPARTMENT
por: Christensen, Erik E., et al.
Publicado: (2022)

IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection
por: Tonby, Kristian, et al.
Publicado: (2015)

Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2021)

Elevated plasma sTIM-3 levels in patients with severe COVID-19
por: Ueland, Thor, et al.
Publicado: (2021)

SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity
por: Mohn, Kristin G-I, et al.
Publicado: (2023)

Fecal level of butyric acid, a microbiome-derived metabolite, is increased in patients with severe carotid atherosclerosis
por: Stø, Kristine, et al.
Publicado: (2022)

Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors
por: Lieske, Nora V., et al.
Publicado: (2015)

A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients
por: Jenum, Synne, et al.
Publicado: (2021)

Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4(+) recovery
por: Stiksrud, Birgitte, et al.
Publicado: (2019)

Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
por: Holter, Jan C., et al.
Publicado: (2020)

Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19
por: Aamodt, Anne Hege, et al.
Publicado: (2021)

The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection
por: Tonby, Kristian, et al.
Publicado: (2016)

Neutrophil count predicts clinical outcome in hospitalized COVID‐19 patients: Results from the NOR‐Solidarity trial
por: Kåsine, Trine, et al.
Publicado: (2021)

Critical COVID‐19 is associated with distinct leukocyte phenotypes and transcriptome patterns
por: Christensen, E. E., et al.
Publicado: (2021)

Soluble Markers of the Toll-Like Receptor 4 Pathway Differentiate between Active and Latent Tuberculosis and Are Associated with Treatment Responses
por: Feruglio, Siri L., et al.
Publicado: (2013)

Omicron Variant Generates a Higher and More Sustained Viral Load in Nasopharynx and Saliva Than the Delta Variant of SARS-CoV-2
por: Granerud, Beathe K., et al.
Publicado: (2022)

Elevated markers of gut leakage and inflammasome activation in COVID‐19 patients with cardiac involvement
por: Hoel, H., et al.
Publicado: (2020)

Low-density lipoprotein particles carrying proinflammatory proteins with altered aggregation pattern detected in COVID-19 patients 3 months after hospitalization
por: Ueland, Thor, et al.
Publicado: (2023)

Human Immunodeficiency Virus–Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction
por: Meyer-Myklestad, Malin Holm, et al.
Publicado: (2020)

Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection
por: Feruglio, S L, et al.
Publicado: (2015)

Risk Factors for Long-Term Mortality after Hospitalization for Community-Acquired Pneumonia: A 5-Year Prospective Follow-Up Study
por: Holter, Jan C., et al.
Publicado: (2016)

Severely ill COVID-19 patients have altered circulating levels of proteins controlling the epitranscriptome()
por: Quiles-Jiménez, A., et al.
Publicado: (2023)

Low fibre intake is associated with gut microbiota alterations in chronic heart failure
por: Mayerhofer, Cristiane C.K., et al.
Publicado: (2020)

Rosuvastatin alters the genetic composition of the human gut microbiome
por: Kummen, Martin, et al.
Publicado: (2020)

Predicting severe COVID-19 in the Emergency Department
por: Holten, Aleksander Rygh, et al.
Publicado: (2020)

Delirium is common in patients hospitalized with COVID-19
por: Watne, Leiv Otto, et al.
Publicado: (2021)

Hepcidin and Ferritin Predict Microbial Etiology in Community-Acquired Pneumonia
por: Oppen, Kjersti, et al.
Publicado: (2021)

Interleukin-6 in Critical Coronavirus Disease 2019, a Driver of Lung Inflammation of Systemic Origin?
por: Aarskog, Nikolai Ravn, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dhkmtol0trj45sq8aiu5ft5t2u